GH-IGF-1 Axis in Children with Cystic Fibrosis

Sara Pagani1, Elena Bozzola2, Gloria Acquafredda3

  • 1Unit of Pediatrics and Adolescentology, Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.

Insights

Children with cystic fibrosis (CF) show improved growth hormone receptor (GHR) gene expression and insulin-like growth factor-I (IGF-I) levels with early diagnosis. Newborn screening for CF may prevent growth retardation by reducing symptom duration.

Area of Science:

  • Pediatric Endocrinology
  • Genetics
  • Pulmonology

Background:

  • Cystic Fibrosis (CF) is a genetic disorder associated with chronic inflammation and malnutrition, potentially impacting growth.
  • The growth hormone receptor (GHR) and insulin-like growth factor-I (IGF-I) axis are crucial for childhood growth.
  • Understanding GHR gene expression in CF patients is important for assessing growth disturbances.

Purpose of the Study:

  • To investigate the role of growth hormone receptor (GHR) gene expression in the growth of children with cystic fibrosis (CF).
  • To compare growth parameters and GHR gene expression between CF patients diagnosed via newborn screening (NBS) versus late diagnosis (LD) and healthy controls.

Main Methods:

  • A cohort of 49 prepubertal children with CF and 52 healthy controls were studied.
  • Blood samples were collected to measure insulin-like growth factor-I (IGF-I), growth hormone-binding protein (GHBP), and GHR gene expression.
  • Body mass index (BMI), height, and weight were compared between groups using ELISA and real-time PCR.

Main Results:

  • CF patients showed significant BMI increase from diagnosis to follow-up, with lower initial median BMI compared to controls.
  • Significantly higher IGF-I and GHBP levels were observed in CF patients (both NBS and LD groups) compared to controls at follow-up.
  • GHR mRNA expression was significantly increased in LD patients and higher in both CF groups compared to controls.

Conclusions:

  • Children with late-diagnosed CF exhibit normal growth hormone/IGF-I axis function and good auxological values.
  • Early diagnosis of CF through newborn screening may further prevent growth retardation by minimizing symptom duration.
  • GHR gene expression appears to play a role in the growth of children with CF, particularly in those with late diagnosis.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
738
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

The goal of this protocol is to showcase the technique and use of point-of-care transient elastography for pediatric gastroenterologists monitoring hepatobiliary involvement and advanced cystic fibrosis liver disease in persons with cystic fibrosis.
442
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
483
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

This protocol describes a cystic fibrosis (CF) lung-relevant four-species polymicrobial biofilm model that can be used to explore the impact of bacterial interspecies...
1.1K
Rectal Organoid Morphology Analysis (ROMA): A Diagnostic Assay in Cystic Fibrosis07:56

Rectal Organoid Morphology Analysis (ROMA): A Diagnostic Assay in Cystic Fibrosis

This protocol describes rectal organoid morphology analysis (ROMA), a novel diagnostic assay for cystic fibrosis (CF). Morphological characteristics, namely the roundness (circularity index, CI) and the presence of a lumen (intensity ratio, IR), are a measure of CFTR function. Analysis of 189 subjects showed perfect discrimination between CF and...
3.2K
Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

This protocol provides methods for visualization of bacterial cells and polysaccharide synthesis locus (Psl) polysaccharide within the sputum of cystic fibrosis...
3.5K